Sen. Warren Urges FDA to Finalize GMO Labeling Guidelines
Calls for FDA to implement policies to promote transparency for consumers
Jul 24, 2013
WASHINGTON, DC -United States Senator Elizabeth Warren (D-MA) and Senator Mark Udall (D-CO) have sent a letter to the Food and Drug Administration (FDA) urging the agency to finalize its policies on the labeling of genetically modified organisms (GMOs) marketed as food products or additives.
"We encourage the FDA to implement a regulatory framework that will promote transparency for consumers while providing producers with the certainty they need to label their products appropriately," Senators Warren and Udall write in the letter. "Standardized labels will prevent misleading or confusing information from being presented to consumers which will help them make informed purchasing decisions that will encourage market competition."
The full text of the letter is available here.